Intercare Hospital Signs MOU with Mitosis Bioscience to Combat Cervical Cancer with US-Standard MOH-Licensed HPV Vaccines

Phnom Penh, January 30, 2026 – Intercare Hospital is proud to announce the official signing of a Memorandum of Understanding (MOU) with Mitosis Bioscience.

The agreement was formally signed by Mr. Jason Harrison, Co-Founder & Deputy CEO of Intercare Hospital, and Dr. Nov Tam, Managing Director & Co-founder of Mitosis Bioscience.

This strategic partnership is dedicated to providing high-quality HPV (Human Papillomavirus) vaccines, licensed by the Ministry of Health and sourced from the United States. Through this collaboration, Intercare Hospital will serve as the premier provider for HPV vaccinations supplied by Mitosis Bioscience, aiming to significantly bolster cervical cancer prevention efforts for women in Cambodia.

As Women’s Health and OB/GYN remain core pillars of our services, ensuring access to internationally recognized preventive care is vital. This initiative aligns perfectly with our slogan “Your Health, Our Mission.”

By combining Intercare’s clinical excellence with the specialized pharmaceutical expertise of Mitosis Bioscience, we are setting a new benchmark for accessible, high-standard preventive healthcare in the Country.

Share this article

MORE NEWS

Stay up to date with us